Article Versions Notes

Dabravolski SA, Sukhorukov VN, Kalmykov VA, Grechko AV, Shakhpazyan NK, Orekhov AN. The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy. Biomedicines. 2022; 10(2):254. https://doi.org/10.3390/biomedicines10020254

Dabravolski, Siarhei A., Vasily N. Sukhorukov, Vladislav A. Kalmykov, Andrey V. Grechko, Nikolay K. Shakhpazyan, and Alexander N. Orekhov. 2022. "The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy" Biomedicines 10, no. 2: 254. https://doi.org/10.3390/biomedicines10020254

Dabravolski, S. A., Sukhorukov, V. N., Kalmykov, V. A., Grechko, A. V., Shakhpazyan, N. K., & Orekhov, A. N. (2022). The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy. Biomedicines, 10(2), 254. https://doi.org/10.3390/biomedicines10020254